The Future of Point-of-Need Diagnostics
Introducing DTECT® (Differential Targeted Endonuclease Cleavage Technology). Our novel isothermal amplification solution breaks the speed limits of traditional PCR — delivering highly specific results in 15 minutes or less.
Moving Beyond Thermal Cycling
Traditional PCR requires precise temperature fluctuations (thermal cycling) to "unzip" DNA and amplify targets. While accurate, the physical limitations of heating and cooling mean that even the fastest PCR platforms bottom out around 30-45 minutes.
Isothermal amplification solves the speed problem by maintaining a constant temperature and using enzymes to unzip the DNA. However, historically, this speed came at a cost: lower specificity and "non-specific amplification" where resources are wasted replicating the wrong targets.
Speed Without Compromise
DTECT® bridges the gap. It utilizes the constant-temperature speed of isothermal amplification but introduces a highly specific, targeted endonuclease mechanism.
1. Targeted Guidance: The enzyme is directed exclusively to the specific target of interest.
2. Resource Efficiency: Eliminates non-specific amplification, ensuring 100% of the reaction's resources go toward the correct target.
3. Extreme Speed: Sample-to-result in under 15 minutes with gold-standard accuracy.
Why DTECT Matters
Built to be administered by anyone, anywhere, without sacrificing lab-quality precision.
Unmatched Speed
Total testing time from raw sample to actionable result in 15 minutes or less, enabling immediate clinical decisions.
Extreme Precision
Differential targeted endonuclease cleavage directs enzymes specifically to the target, eliminating non-specific amplification and resource waste.
Field-Ready Automation
Fully automated process requiring minimal sample volume. Administered easily by non-lab technicians at the point of need.
First DTECT Applications
DTECT is moving rapidly from the lab to the field. Here are the first diagnostic panels currently in development that will utilize this breakthrough technology.
Host Response
Integration into our Host Response pipeline to provide rapid differentiation between bacterial and viral infections.
Biowarfare Panel
Deployment in our biodefense suite for ultra-rapid detection of CBRN threats in contested environments.
Experience the Next Generation
DTECT® technology will be deployed on our advanced molecular testing hardware, including the upcoming Biomeme/5 platform.